Indoco Remedies Limited

₹203.33-0.44%Feb 27, 2:00 PM IST

INDOCO•Health Technology•Pharmaceuticals: Major

Current Price

₹203.33-0.44%

Feb 27, 2:00 PM IST

Market Cap₹1,885.76 Cr

Business Overview

Indoco Remedies Limited operates through 5 main business divisions including Domestic Formulations, Export Formulations, API, IAS & CRO, Subsidiaries, Associates.

Business Hierarchy Structure for Indoco Remedies Limited

Indoco Remedies Limited
- Domestic Formulations
  - Indoco Pharma
    - Therapeutic Segments & Products
      - Stomatologicals
        SENSODENT-K
        SENSOFORM
        KIDODENT
        REXIDIN-M
        SENSODENT-KF
        DENTOGEL
      - Ophthal / Otologicals
        HOMIDE
        DEXOREN-S
        RENOLEN
        MOFLOREN-BF
        OTOREX
        MOFLOREN-D
        ZINCOREN
        MACUCHEK
        CLYGAN
        DEXOREN-SP
      - Pain / Analgesics
        LORCHEK-MR
        LIGNOX+ADRENLINE
        T-LAC
      - Respiratory
        KARVOL PLUS
        FEBREX PLUS
        FEDRIS
      - Dermatology
        NINAF
        NOXA
        SCABEX
        CLOBEN-G
      - Gastro Intestinal
        CYCLOPAM
        CARMICIDE
        CYCLOMEFF
      - Urology
        CITAL-UTI
        CITAL
      - Blood Related
        HEMSYL
      - Anti-Infectives
        VEPAN
        VEPAN CV
        Bactogard
        ATM
        ATM-A
      - Anti Diabetic
        ALOJA
      - Vitamins/Minerals/ Nutrients
        SM FIBRO
      - Primary Care medicines
      - Cardiology
      - Metabolic Disorders
      - Women's Health
        MCBM 69
        METHYCAL
        NOSIC
        D-CHIRO PLUS
        Methycal 2000
        Ladyboon
      - Anti-Hypertensive
      - Protein Supplements
      - Multivitamin range of tablets & syrups
      - Antibiotics tablets, syrups and Injectable
      - Oral Rehydration Powders
      - Antacids
      - Antihistaminic Tablets
    - New Product Launches
      - Biltal M Suspension (Respiratory Segment)
      - Biltal M Tablets (Respiratory Segment)
      - Lygylac Sachet (Gastro-Intestinal Segment)
      - Noxa (Topical antibacterial products)
      - Dropizin
  - Warren Division
    - Dental Sensitivity Market
- Export Formulations
  - North America
    - Oral Solids (under FPP label)
    - Injectable product (under FPP label)
  - Europe
    - New products in Germany
    - New products in UK
    - HYLUPRO (Sodium Hyaluronate)
    - BRITIGAN (Brimonidine+Timolol)
  - South Africa
  - Australia
  - New Zealand
    - Oral Solids
  - Asia
    - Sri Lanka
    - Myanmar
    - Malaysia
  - MENA
    - Afghanistan
  - CIS
  - LATAM
- API, IAS & CRO
  - API Business
    - Manufacturing Facilities
      - Patalganga (Maharashtra)
      - Rabale (Navi Mumbai)
      - Aurangabad (Maharashtra)
    - Therapeutic Categories
      - Anti-diabetic APIs
      - Anti-gout APIs
      - Ophthalmic APIs
  - AnaCipher (CRO)
    - Clinical Research Services
      - Pharmacovigilance
      - Bio-availability
      - Bio-equivalence
      - Pharmacokinetics
      - Food effect
      - Taste evaluation
      - Steady state studies
      - Multiple dose studies
  - Indoco Analytical Solutions (IAS), Rabale
    - Public testing laboratory
    - Services
      - Nitrosamine testing
      - Genotoxic impurities testing
      - Azido impurities testing
      - NAP test for APIs
      - Extractable & Leachable (E&L) studies
      - De-formulation studies
      - Elemental impurities assessment
      - Crystallographic services
- Subsidiaries
  - Xtend Industrial Designers and Engineers Private Limited
  - Warren Remedies Private Limited
  - Indoco Remedies Czech S.R.O.
  - Indoco Remedies UK Limited
  - FPP Holding Company, LLC
- Associates
  - Jalansar Wind Energy Private Limited
  - Kanakal Wind Energy Private Limited